PTC Therapeutics PTCT Business Segments — Income Tax Expense Benefit

Similar metrics at other companies

LNCLife Insurance — Federal income tax expense (benefit)

$1M+106%

IBRXReportable Segment — Income Tax Expense (Benefit)

$9K+104%

STWDCommercial and Residential Lending Segment — Income Tax Expense (Benefit)

-$11.73M-4,089%

PNW

PNWReportable Segment — Income Tax Expense (Benefit)

-$1M-117%

ROIVReportable Segment — Income tax expense (benefit)

$98.35M+99.4%

PFGSegment Corporate — Income Tax Expense Benefit

-$25.65M-21.3%

Questions, answered.

What is PTC Therapeutics's business segments — income tax expense benefit?

PTC Therapeutics (PTCT) reported business segments — income tax expense benefit of $347K in Q1 2026.

How has PTC Therapeutics's business segments — income tax expense benefit changed year-over-year?

PTC Therapeutics's business segments — income tax expense benefit decreased by 99.5% year-over-year, from $63.27M to $347K.

What does business segments — income tax expense benefit mean?

This metric captures the provision for income taxes or the benefit derived from tax credits and adjustments specifically attributed to the Life Science segment's operations. It reflects the fiscal impact of tax jurisdictions on the segment's bottom line. Analyzing this figure assists in understanding the effective tax rate and the impact of tax planning on the segment's net financial performance.